FDA Approved: LEVETIRACETAM — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for Levetiracetam from Hisun Pharmaceuticals USA, Inc. to bring a generic product to market (ANDA207175).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)